A tiny mesh could be implanted into damaged joints to encourage the growth of new cartilage, with the help of steady electrical currents, report experts in Storrs, Connecticut.
Around 25,000 rheumatoid arthritis patients are to benefit from new drugs approved for use on the NHS.
The National Institute for Health and Care Excellence gave the green light to several drugs for people with a moderate form of the disease who have not responded to conventional therapies.
The drugs are adalimumab, etanercept and infliximab, taken with methotrexate for use in the NHS.
Dr Natalie Carter, of Versus Arthritis, said the drugs will enable thousands more people to benefit from these treatments . Rheumatoid arthritis is a long-term condition that causes pain, swelling and stiffness in the joints and around 400,000 people are affected.
It’s been almost 10 years since the world was warned of a post-antibiotic apocalypse. Katrina Megget takes a look at the initiatives trying to support antimicrobial R&D
Cholesterol-lowering drugs given green light for NHS use 28/04/2021, 2:23 pm
The National Institute for Health and Care Excellence has approved bempedoic acid with ezetimibe for NHS use (Julien Behal/PA)
Thousands of patients with high cholesterol are set to benefit from a treatment after health officials said that it could be used in the NHS.
Adults in England who have primary hypercholesterolaemia or mixed dyslipidaemia – also known as high cholesterol – will now be eligible for treatment with two new types of once-daily pills.
The National Institute for Health and Care Excellence (Nice) has approved bempedoic acid with ezetimibe for NHS use for patients who have high levels of low-density lipoprotein cholesterol (LDL-C), also known as “bad” cholesterol, and are unable to take statins.